| Literature DB >> 35246769 |
Hayes H Patrick1, Jonathan H Sherman2, J Bradley Elder3, Jeffrey J Olson4.
Abstract
QUESTION: In patients with previously diagnosed glioblastoma who are suspected of experiencing progression, does repeat cytoreductive surgery improve progression free survival or overall survival compared to alternative interventions? TARGET POPULATION: These recommendations apply to adults with previously diagnosed glioblastoma who are suspected of experiencing progression of the neoplastic process and are amenable to surgical resection. RECOMMENDATION: Level II: Repeat cytoreductive surgery is recommended in progressive glioblastoma patients to improve overall survival.Entities:
Keywords: Cytoreductive surgery; Glioblastoma; Recurrent
Mesh:
Year: 2022 PMID: 35246769 DOI: 10.1007/s11060-021-03881-w
Source DB: PubMed Journal: J Neurooncol ISSN: 0167-594X Impact factor: 4.130